We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WNR
151
DELISTED
Western Refining Inc
WNR
| $1.41M | 0.2% |
+48,606
| New | +$1.47M |
|
|
DTLK
152
DELISTED
Datalink Corp
DTLK
| $1.41M | 0.2% |
+154,303
| New | +$1.12M |
|
|
BELFB
153
Bel Fuse Inc Class B
BELFB
$3.88B
| $1.41M | 0.2% |
96,524
-145,822
| -60% | -$2.16M |
|
154
Darling Ingredients
DAR
$9.93B
| $1.39M | 0.2% |
105,190
+8,444
| +9% | +$85.1K |
|
155
Titan International
TWI
$516M
| $1.38M | 0.2% |
256,502
+72,573
| +39% | +$302K |
|
156
Scorpio Tankers
STNG
$3.96B
| $1.37M | 0.2% |
23,576
-53,569
| -69% | -$3.17M |
|
|
IIP
157
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $1.37M | 0.2% |
502,417
+467,428
| +1,336% | +$1.28M |
|
|
ODP
158
DELISTED
ODP
ODP
| $1.37M | 0.2% |
+19,264
| New | +$1.04M |
|
|
NUVA
159
DELISTED
NuVasive, Inc.
NUVA
| $1.36M | 0.2% |
+28,026
| New | +$1.27M |
|
160
NACCO Industries
NC
$353M
| $1.36M | 0.2% |
103,779
-63,904
| -38% | -$709K |
|
161
EXL Service
EXLS
$4.23B
| $1.36M | 0.2% |
131,155
-117,245
| -47% | -$1.08M |
|
|
ENZ
162
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.36M | 0.2% |
298,557
-149,490
| -33% | -$665K |
|
|
SHOE
163
Shoe Station Group
SHOE
$395M
| $1.35M | 0.2% |
100,446
-48,134
| -32% | -$572K |
|
164
Modine Manufacturing
MOD
$12.8B
| $1.34M | 0.19% |
121,557
+41,007
| +51% | +$348K |
|
165
Par Pacific Holdings
PARR
$3.88B
| $1.34M | 0.19% |
71,212
-32,677
| -31% | -$701K |
|
|
ASRT
166
DELISTED
Assertio
ASRT
| $1.33M | 0.19% |
1,591
-3,358
| -68% | -$3.11M |
|
167
CorVel
CRVL
$3.05B
| $1.33M | 0.19% |
101,238
-101,046
| -50% | -$1.42M |
|
|
RICE
168
DELISTED
Rice Energy Inc.
RICE
| $1.33M | 0.19% |
95,110
-79,561
| -46% | -$827K |
|
|
JBTM
169
JBT Marel
JBTM
$7.14B
| $1.33M | 0.19% |
+23,524
| New | +$1.14M |
|
|
DMC
170
Del Monte Corp
DMC
$1.35B
| $1.33M | 0.19% |
31,524
+8,324
| +36% | +$338K |
|
|
BCOV
171
DELISTED
Brightcove, Inc.
BCOV
| $1.32M | 0.19% |
211,364
+194,669
| +1,166% | +$1.13M |
|
|
CCF
172
DELISTED
Chase Corporation
CCF
| $1.32M | 0.19% |
+25,071
| New | +$1.16M |
|
|
CAI
173
DELISTED
CAI International, Inc.
CAI
| $1.31M | 0.19% |
136,107
+62,500
| +85% | +$470K |
|
|
SP
174
DELISTED
SP Plus Corporation
SP
| $1.31M | 0.19% |
54,504
+9,030
| +20% | +$209K |
|
|
GNC
175
DELISTED
GNC Holdings, Inc.
GNC
| $1.31M | 0.19% |
+41,275
| New | +$1.18M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.